Investor Relations

We are committed to serving the best interests of our shareholders. You will find key shareholder information and financial reports available to help put KaloBios' financial performance into perspective.

September 15,2014, Interview with David W. Pritchard, President and CEO

View all »   RSSRecent Releases

Jan 8, 2015
KaloBios Announces Retirement of David W. Pritchard, President and Chief Executive Officer

Jan 6, 2015
KaloBios Reports Top-Line Data for Phase 2 Study of KB001-A to Treat Pseudomonas Aeruginosa Lung Infections in Cystic Fibrosis Patients

Shareholder Tools

Search Investor Relations

You are now leaving this website. If you would like to continue, click Continue.